img

Global Visceral Pain Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Visceral Pain Market Research Report 2024

Visceral pain is pain that results from the activation of nociceptors of the thoracic, pelvic, or abdominal viscera (organs). Visceral structures are highly sensitive to distension (stretch), ischemia and inflammation, but relatively insensitive to other stimuli that normally evoke pain such as cutting or burning. Visceral pain is diffuse, difficult to localize and often referred to a distant, usually superficial, structure. It may be accompanied by symptoms such as nausea, vomiting, changes in vital signs as well as emotional manifestations. The pain may be described as sickening, deep, squeezing, and dull. Distinct structural lesions or biochemical abnormalities explain this type of pain in only a proportion of patients. These diseases are grouped under gastrointestinal neuromuscular diseases (GINMD). Others can experience visceral pains, often very intense in nature, without any evidence of structural, biochemical or histolopathologic reason for such symptoms. These diseases are grouped under functional gastrointestinal disorders (FGID) and the pathophysiology and treatment can vary greatly from GINMD. The two major single entities among functional disorders of the gut are functional dyspepsia and irritable bowel syndrome.
According to Mr Accuracy reports’s new survey, global Visceral Pain market is projected to reach US$ 1315.3 million in 2034, increasing from US$ 989.4 million in 2024, with the CAGR of 3.7% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Visceral Pain market research.
Growing focus on research and development by pharmaceutical companies and government initiatives are expected to boost the visceral pain industry over the forecast period. The market is projected to witness significant gain during the forecast period owing to increasing collaboration within pharmaceutical companies. Moreover, growth in the interest of scientists and researchers in studying the pain originating from internal organs has mirrored in the consciousness of the importance of visceral pain in patients. Asia Pacific is expected to grow at the highest CAGR of 6.2% from 2017 to 2024. North America has been leading the market for visceral pain, it is expected that African countries will witness exponential growth during the forecast period.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Visceral Pain market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer
Johnson & Johnson
Abbvie
Takeda
Allergan
AstraZeneca
Segment by Type
Analgesics
Pain Modifiers

Segment by Application


Interstitial Cystitis
Crohn’s
Irritable Bowel
Chronic Prostatitis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Visceral Pain report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Visceral Pain Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Analgesics
1.2.3 Pain Modifiers
1.3 Market by Application
1.3.1 Global Visceral Pain Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Interstitial Cystitis
1.3.3 Crohn’s
1.3.4 Irritable Bowel
1.3.5 Chronic Prostatitis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Visceral Pain Market Perspective (2018-2034)
2.2 Visceral Pain Growth Trends by Region
2.2.1 Global Visceral Pain Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Visceral Pain Historic Market Size by Region (2018-2023)
2.2.3 Visceral Pain Forecasted Market Size by Region (2024-2034)
2.3 Visceral Pain Market Dynamics
2.3.1 Visceral Pain Industry Trends
2.3.2 Visceral Pain Market Drivers
2.3.3 Visceral Pain Market Challenges
2.3.4 Visceral Pain Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Visceral Pain Players by Revenue
3.1.1 Global Top Visceral Pain Players by Revenue (2018-2023)
3.1.2 Global Visceral Pain Revenue Market Share by Players (2018-2023)
3.2 Global Visceral Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Visceral Pain Revenue
3.4 Global Visceral Pain Market Concentration Ratio
3.4.1 Global Visceral Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Visceral Pain Revenue in 2024
3.5 Visceral Pain Key Players Head office and Area Served
3.6 Key Players Visceral Pain Product Solution and Service
3.7 Date of Enter into Visceral Pain Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Visceral Pain Breakdown Data by Type
4.1 Global Visceral Pain Historic Market Size by Type (2018-2023)
4.2 Global Visceral Pain Forecasted Market Size by Type (2024-2034)
5 Visceral Pain Breakdown Data by Application
5.1 Global Visceral Pain Historic Market Size by Application (2018-2023)
5.2 Global Visceral Pain Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Visceral Pain Market Size (2018-2034)
6.2 North America Visceral Pain Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Visceral Pain Market Size by Country (2018-2023)
6.4 North America Visceral Pain Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Visceral Pain Market Size (2018-2034)
7.2 Europe Visceral Pain Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Visceral Pain Market Size by Country (2018-2023)
7.4 Europe Visceral Pain Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Visceral Pain Market Size (2018-2034)
8.2 Asia-Pacific Visceral Pain Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Visceral Pain Market Size by Region (2018-2023)
8.4 Asia-Pacific Visceral Pain Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Visceral Pain Market Size (2018-2034)
9.2 Latin America Visceral Pain Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Visceral Pain Market Size by Country (2018-2023)
9.4 Latin America Visceral Pain Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Visceral Pain Market Size (2018-2034)
10.2 Middle East & Africa Visceral Pain Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Visceral Pain Market Size by Country (2018-2023)
10.4 Middle East & Africa Visceral Pain Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Visceral Pain Introduction
11.1.4 Pfizer Revenue in Visceral Pain Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Visceral Pain Introduction
11.2.4 Johnson & Johnson Revenue in Visceral Pain Business (2018-2023)
11.2.5 Johnson & Johnson Recent Development
11.3 Abbvie
11.3.1 Abbvie Company Detail
11.3.2 Abbvie Business Overview
11.3.3 Abbvie Visceral Pain Introduction
11.3.4 Abbvie Revenue in Visceral Pain Business (2018-2023)
11.3.5 Abbvie Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Visceral Pain Introduction
11.4.4 Takeda Revenue in Visceral Pain Business (2018-2023)
11.4.5 Takeda Recent Development
11.5 Allergan
11.5.1 Allergan Company Detail
11.5.2 Allergan Business Overview
11.5.3 Allergan Visceral Pain Introduction
11.5.4 Allergan Revenue in Visceral Pain Business (2018-2023)
11.5.5 Allergan Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Visceral Pain Introduction
11.6.4 AstraZeneca Revenue in Visceral Pain Business (2018-2023)
11.6.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Visceral Pain Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Analgesics
Table 3. Key Players of Pain Modifiers
Table 4. Global Visceral Pain Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Visceral Pain Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Visceral Pain Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Visceral Pain Market Share by Region (2018-2023)
Table 8. Global Visceral Pain Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Visceral Pain Market Share by Region (2024-2034)
Table 10. Visceral Pain Market Trends
Table 11. Visceral Pain Market Drivers
Table 12. Visceral Pain Market Challenges
Table 13. Visceral Pain Market Restraints
Table 14. Global Visceral Pain Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Visceral Pain Market Share by Players (2018-2023)
Table 16. Global Top Visceral Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Visceral Pain as of 2024)
Table 17. Ranking of Global Top Visceral Pain Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Visceral Pain Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Visceral Pain Product Solution and Service
Table 21. Date of Enter into Visceral Pain Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Visceral Pain Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Visceral Pain Revenue Market Share by Type (2018-2023)
Table 25. Global Visceral Pain Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Visceral Pain Revenue Market Share by Type (2024-2034)
Table 27. Global Visceral Pain Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Visceral Pain Revenue Market Share by Application (2018-2023)
Table 29. Global Visceral Pain Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Visceral Pain Revenue Market Share by Application (2024-2034)
Table 31. North America Visceral Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Visceral Pain Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Visceral Pain Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Visceral Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Visceral Pain Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Visceral Pain Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Visceral Pain Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Visceral Pain Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Visceral Pain Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Visceral Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Visceral Pain Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Visceral Pain Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Visceral Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Visceral Pain Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Visceral Pain Market Size by Country (2024-2034) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Visceral Pain Product
Table 49. Pfizer Revenue in Visceral Pain Business (2018-2023) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Johnson & Johnson Company Detail
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson Visceral Pain Product
Table 54. Johnson & Johnson Revenue in Visceral Pain Business (2018-2023) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. Abbvie Company Detail
Table 57. Abbvie Business Overview
Table 58. Abbvie Visceral Pain Product
Table 59. Abbvie Revenue in Visceral Pain Business (2018-2023) & (US$ Million)
Table 60. Abbvie Recent Development
Table 61. Takeda Company Detail
Table 62. Takeda Business Overview
Table 63. Takeda Visceral Pain Product
Table 64. Takeda Revenue in Visceral Pain Business (2018-2023) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. Allergan Company Detail
Table 67. Allergan Business Overview
Table 68. Allergan Visceral Pain Product
Table 69. Allergan Revenue in Visceral Pain Business (2018-2023) & (US$ Million)
Table 70. Allergan Recent Development
Table 71. AstraZeneca Company Detail
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Visceral Pain Product
Table 74. AstraZeneca Revenue in Visceral Pain Business (2018-2023) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Visceral Pain Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Visceral Pain Market Share by Type: 2024 VS 2034
Figure 3. Analgesics Features
Figure 4. Pain Modifiers Features
Figure 5. Global Visceral Pain Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Visceral Pain Market Share by Application: 2024 VS 2034
Figure 7. Interstitial Cystitis Case Studies
Figure 8. Crohn’s Case Studies
Figure 9. Irritable Bowel Case Studies
Figure 10. Chronic Prostatitis Case Studies
Figure 11. Visceral Pain Report Years Considered
Figure 12. Global Visceral Pain Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Visceral Pain Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Visceral Pain Market Share by Region: 2024 VS 2034
Figure 15. Global Visceral Pain Market Share by Players in 2024
Figure 16. Global Top Visceral Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Visceral Pain as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Visceral Pain Revenue in 2024
Figure 18. North America Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Visceral Pain Market Share by Country (2018-2034)
Figure 20. United States Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Visceral Pain Market Share by Country (2018-2034)
Figure 24. Germany Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Visceral Pain Market Share by Region (2018-2034)
Figure 32. China Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Visceral Pain Market Share by Country (2018-2034)
Figure 40. Mexico Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Visceral Pain Market Share by Country (2018-2034)
Figure 44. Turkey Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Visceral Pain Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Visceral Pain Business (2018-2023)
Figure 47. Johnson & Johnson Revenue Growth Rate in Visceral Pain Business (2018-2023)
Figure 48. Abbvie Revenue Growth Rate in Visceral Pain Business (2018-2023)
Figure 49. Takeda Revenue Growth Rate in Visceral Pain Business (2018-2023)
Figure 50. Allergan Revenue Growth Rate in Visceral Pain Business (2018-2023)
Figure 51. AstraZeneca Revenue Growth Rate in Visceral Pain Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries